Clinical Trial Update: A First-in-Human Study of LY3009385 in Healthy Participants [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial of LY3009385 in healthy participants to evaluate safety, tolerability, and pharmacokinetics; the study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY3009385

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2014-10-06